Status:
RECRUITING
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Conditions:
Thyroid Cancer
Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.
Detailed Description
Targeted radionuclide therapy (TRT) aims at delivering ionizing radiation specifically to tumors for therapeutic purposes. Different types of radionuclides can be used to deliver the radiation: beta e...
Eligibility Criteria
Inclusion
- Age ≥ at 18 years old,
- Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,
- Patient treated as part of his treatment for:
- thyroid cancer,
- a neuroendocrine tumor or
- prostate cancer.
- Patient having accepted the complementary blood sample,
- Patient having given his informed, written and express consent.
Exclusion
- Patient not affiliated to a social security scheme,
- Subject under tutelage, curatorship or safeguard of justice,
- Patient in an emergency situation
- Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons,
- Pregnant and / or breastfeeding woman
Key Trial Info
Start Date :
October 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04104529
Start Date
October 28 2019
End Date
October 1 2026
Last Update
November 20 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Haut Lévêque
Bordeaux, Aquitaine, France
2
Hôpital LaTimone
Marseille, Bouches Du Rhône, France
3
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Montpellier, France, 34298
4
Institut Universitaire du Cancer de Toulouse
Toulouse, France, 31100